During the past decade, Centre de Recherche Clinique de Laval conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherche Clinique de Laval" #1 sponsor was "Pfizer" with 4 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Aegera Therapeutics" with 1 trials sponsored, "BioSyntech Canada Inc." with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche Clinique de Laval" #1 collaborator was "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherche Clinique de Laval" are "Type 2 Diabetes Mellitus" (4 trials), "Diabetic Kidney Disease" (2 trials), "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Centre de Recherche Clinique de Laval" in a lesser frequency.

Most popular intervention types in "Centre de Recherche Clinique de Laval" are "Drug" (13 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "PF-04950615 (RN316)" (2 trials), "Tirzepatide" (2 trials), "AEG33773 oral dosing" (1 trials) and "BMS-813160" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherche Clinique de Laval" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de Recherche Clinique de Laval". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre de Recherche Clinique de Laval, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherche Clinique de Laval, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".